Skip to main content
. 2022 Sep 16;12:932563. doi: 10.3389/fcimb.2022.932563

Figure 4.

Figure 4

Prevalence and frequency of antibodies and symptoms among symptomatic and asymptomatic individuals. (A) Percentage of +/- anti-SARS-CoV-2 IgG antibodies between symptomatic and asymptomatic individuals. (B) Frequency of symptoms characteristic of COVID-19. ns, not significant.